These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25981178)

  • 41. Clozaphobia: Is avoidance of clozapine in diabetes warranted?
    Sreeraj VS; Dinakaran D; Nagendrappa S; Rao NP; Kesavan M; Varambally S; Venkatasubramanian G
    Asian J Psychiatr; 2017 Aug; 28():142-145. PubMed ID: 28784368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Obsessive-Compulsive Symptoms in a Sample of Patients with Chronic Schizophrenia Under Clozapine Treatment].
    Schreiter S; Hasan A; Majic T; Wullschleger A; Schouler-Ocak M; Bermpohl F; Gutwinski S
    Fortschr Neurol Psychiatr; 2016 Nov; 84(11):675-681. PubMed ID: 27846652
    [No Abstract]   [Full Text] [Related]  

  • 43. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study.
    Henderson DC; Nguyen DD; Copeland PM; Hayden DL; Borba CP; Louie PM; Freudenreich O; Evins AE; Cather C; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1116-21. PubMed ID: 16187768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between HTR2C polymorphisms and metabolic syndrome in patients with schizophrenia treated with atypical antipsychotics.
    Bai YM; Chen TT; Liou YJ; Hong CJ; Tsai SJ
    Schizophr Res; 2011 Feb; 125(2-3):179-86. PubMed ID: 21185157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm.
    Waterreus AJ; Laugharne JD
    Med J Aust; 2009 Feb; 190(4):185-9. PubMed ID: 19220182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.
    Wysokiński A; Sobów T
    Nord J Psychiatry; 2016; 70(2):156-60. PubMed ID: 26140393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics.
    Sanchez-Martinez V; Romero-Rubio D; Abad-Perez MJ; Descalzo-Cabades MA; Alonso-Gutierrez S; Salazar-Fraile J; Montagud V; Facila L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):379-387. PubMed ID: 29165095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
    Pallava A; Chadda RK; Sood M; Lakshmy R
    Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
    Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
    Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine.
    Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Leinonen E
    Psychiatry Res; 2014 Aug; 218(3):277-83. PubMed ID: 24837425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.
    Saari KM; Lindeman SM; Viilo KM; Isohanni MK; Järvelin MR; Laurén LH; Savolainen MJ; Koponen HJ
    J Clin Psychiatry; 2005 May; 66(5):559-63. PubMed ID: 15889940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Boyer L; Richieri R; Dassa D; Boucekine M; Fernandez J; Vaillant F; Padovani R; Auquier P; Lancon C
    Psychiatry Res; 2013 Dec; 210(2):381-6. PubMed ID: 23850204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.
    Suetani RJ; Siskind D; Reichhold H; Kisely S
    Psychopharmacology (Berl); 2017 Oct; 234(20):2989-3008. PubMed ID: 28879574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey.
    Sahpolat M; Ari M
    Nord J Psychiatry; 2021 Jan; 75(1):73-78. PubMed ID: 32886012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders.
    Abdel Aziz K; Mohd Ahmed H; Stip E; Aly El-Gabry D
    Int Clin Psychopharmacol; 2024 Jul; 39(4):257-266. PubMed ID: 38381917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
    Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M
    Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.